Network Medicine

Blueprint for antimicrobial hit discovery targeting metabolic networks

Proceedings of the National Academy of Sciences of the United States of America 10.1073, 1-6 (2010) Advances in genome analysis, network biology, and computational chemistry have the potential to revolutionize drug discovery by combining system-level identification of drug targets with the atomistic modeling of small molecules capable of modulating their activity. To demonstrate the effectiveness of such a discovery pipeline, we deduced common antibiotic targets in Escherichia coli and Staphylococcus aureus by identifying shared tissue-specific or uniformly essential metabolic reactions in their metabolic networks. We then predicted through virtual screening dozens of potential inhibitors for several enzymes of these reactions and showed experimentally that a subset of these inhibited both enzyme activities in vitro and bacterial cell viability. This blueprint is applicable for any sequenced organism with high-quality metabolic reconstruction and suggests a general strategy for strain-specific antiinfective therapy.


More publications
A. Vazquez, J.G. Oliveira, Z. Dezso, K.I. Goh, I. Kondor, A.-L. Barabási

Physical Review E 73, 036127 (2006)

C. Song, Z. Qu, N. Blumm, A.-L. Barabási

Nature Physics 7, 713- (2010)

M. C. González, C. A. Hidalgo, A.-L. Barabási

Nature 453, 779-782 (2008)